
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.
New Haven, Connecticut
Joined September 2012
- Tweets10.3K
- Following1.8K
- Followers17.4K
- Likes10K
Cancer breakthroughs coming out of Yale labs have drawn major pharmaceutical giants into #Connecticut.
"This is a time that is more exciting in #cancer medicine than any time any of us have ever seen, and every year it gets better," said @DrEricWiner.
finance.yahoo.com/healthcare…
@SmilowCancer @YNHH @BioCT_org
2
177
Congratulations @Dr_AmerZeidan, 2026 King Hussein Cancer Research Award recipient for Lifetime Achievement – International Track from @KHCFKHCC. The awards aim to encourage Arab researchers and scientists from around the world to elevate #cancerresearch and advance the fight against #cancer and overcome it through cutting-edge scientific approaches.
jordantimes.com/news/local/d…
@SmilowCancer @YaleHematology @YNHH
Congratulations to Dr. Elena Ratner, chief of gynecologic oncology, for being named to the inaugural #KIND100 list! KIND100 is a new annual global recognition by @kindness_org celebrating 100 extraordinary individuals whose actions are helping build a kinder, more compassionate, and resilient world.
kindness.org/kind100/
@SmilowCancer @YaleObGynRes @YNHH
Chef Dietitian Max Goldstein, MS, RDN, CDN, CCMS from the @ynhhealth Teaching Kitchen, talks about #culinarymedicine and how teaching patients new skills and making small, simple changes in the kitchen can inspire confidence in preparing #healthyfood at home.
📶Listen live @wnpr
🎧Listen later @ApplePodcasts, @Spotify, @YouTube
@SmilowCancer @YNHH
220
According to @DrEricWiner and Dr. Peter Glazer @GlazerLab, the benefits of the new proton beam therapy #PBT center far outweigh the costs.
healthleadersmedia.com/cmo/c…
@SmilowCancer @YNHH @YaleRadOnc
Yale Cancer Center retweeted
We are thrilled to share that this year’s @CTFRide has raised more than $4M, and fundraising continues through the end of 2026! Every dollar raised directly supports #patientcare and #cancerresearch at @SmilowCancer and @YaleCancer.
A heartfelt thank you to all of the riders, volunteers, and supporters who have made this incredible achievement possible! 🚲💙
vimeo.com/1245825279
@YNHH #CTFRide
New reference ranges were established for individuals with Duffy-null status in a recent study that will help clinicians accurately determine normal and abnormal white blood cell counts, preventing unnecessary testing.
medicine.yale.edu/cancer/new…
@SmilowCancer @GeorgeGoshuaMD @cececalhounMD @ASH_hematology @BloodAdvances
Even with major advances in oncology—from cancer vaccines to immunotherapy—a large subset of patients aren’t getting the right treatment due to socio-economic factors, explains @DrEricWiner at the recent Future of Oncology Summit.
ctinsider.com/business/artic…
@SmilowCancer @YaleMed @YNHH @BioCT_org
We are pleased to share the autumn 2026 issue of #Breakthroughs is now available! Breakthroughs highlights our continued commitment to putting patients first at @YaleCancer and @SmilowCancer through personalized medicine, innovative research, and advancements in cancer treatment.
➡️medicine.yale.edu/breakthrou…
@YaleMed @YNHH @YaleMedicine
Mild pre-surgery swallowing impairment predicts severe post-op swallowing difficulty in #HPV-positive patients with #oropharyngealcancer according to a new study from Dr. Barbara Burtness.
medicine.yale.edu/cancer/pub…
@SmilowCancer
3
345
A study from @kturaga et al. found 24.6% of patients with #appendixcancer had a prior autoimmune diagnosis and distinct epigenetic patterns linked to immune and cancer pathways.
medicine.yale.edu/cancer/pub…
@SmilowCancer @YaleGICancers @SciReports @YaleSurgery
More than 300 #clinicaltrials are currently open to new patients at Yale Cancer Center, offering a glimpse of advances in cancer treatment and how many modern #cancer drugs are tailored to patients based on biomarkers and genetic testing. “To get the most cutting-edge treatment, really clinical trials is a great option,” says Dr. Ian Krop, chief clinical research officer.
ctpost.com/business/article/…
@SmilowCancer
Thanks to a longstanding collaboration between #VAConnecticut, @SmilowCancer and @YaleCancer, Veterans in Connecticut have access to highly specialized, multidisciplinary cancer care close to home.
medicine.yale.edu/news-artic…
@SmilowCancer @YNHH @YaleMed
As today's Future of Oncology Summit gathered leaders from across oncology, pharma, and biotech to shape the future of #cancer care, @DrEricWiner says: “It’s a time when we get scientists and people in industry and clinicians all together with the purpose of trying to come up with new therapies that will ultimately have an impact on our patients that we see every day."
➡️Watch: bit.ly/3UF2IR1
@SmilowCancer @YaleMed @YNHH
Cancer research and treatment have entered a “golden age,” with #artificialintelligence helping accelerate scientific discoveries and creating new opportunities for biotechnology companies and investors, industry leaders said at the Future of Oncology Summit, hosted by @BioCT_org and @YaleCancer.
hartfordbusiness.com/article…
@SmilowCancer @YNHH @YaleMed
.@GovNedLamont stressed the importance of supporting an ecosystem and environment in CT for growth in #Biotech and life sciences @BioCT_org Future of Oncology Summit. @SmilowCancer @YaleMed @YNHH
.@CliffordHudis discusses the positive impact #AI will continue to have on patient outcomes, scientific advances, and the medical profession in the coming years at the @BioCT_org Future of Oncology Summit. @ASCO @SmilowCancer
Jodie Gillon @BioCT_org and @DrEricWiner welcome guests to the Future of Oncology Summit, urging collaboration and innovation among attendees from academia, industry, advocacy & government. @SmilowCancer @YaleMed @YNHH
A Yale study led by @YangLiu_Yale presents a spatially-resolved epigenomic atlas of NF-PanNETs across tumor grades, providing new insights into epigenetic heterogeneity and tumor-stroma interactions & a foundation for future functional and clinical investigation.
medicine.yale.edu/cancer/pub…
@SmilowCancer @YaleGICancers @iScience_CP @PamelaKunzMD @Cecchini_OncMD @yalepathology @NeurologyYale
Hematologist and leader of the Yale Myeloma Team, @NataliaNeparid1 joins #YaleCancerAnswers tonight to talk in depth about CAR T-cell therapy and how it benefits patients with #myeloma.
🎧Listen live at 7:30pm @wnpr
💻Listen later @ApplePodcasts, @Spotify, @YouTube
@SmilowCancer @YaleHematology @YNHH












